Watch Out for Bleeding in These Cancer Patients on Extended Anticoagulation

By News Health
2 months Ago

(MedPage Today) — ORLANDO — Researchers identified four predictors of clinically relevant bleeding in patients receiving extended anticoagulation with apixaban (Eliquis) for cancer-associated venous thromboembolism (VTE).
Over a median follow…

Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118933

Author :

Publish date : 2025-12-10 18:27:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

EPA Revokes Finding That Helped Fight Climate Change: Here's What to Know

Bad Bunny Meets Public Health; Docs Are the Worst Patients; When Ortho Runs Rounds

Potentially Blinding Eye Condition Tied to Ozempic Again

FDA Approves Wearable Device to Treat Pancreatic Cancer

Is One Salvage Strategy Best in Localized Prostate Cancer?

Safety of Crohn's Disease Meds; Boosting CRC Screening; BMI and Liver Risks